Results 101 to 110 of about 131,644 (347)
DYSPEPSIA AND HEARTBURN
Rheumatic Disease Clinics of North America, 1999 Dyspepsia and heartburn are the two cardinal symptoms of foregut dysfunction. When confronting such a problem, that physician must first learn to discern between the two, because treatment can be quite different for the conditions presenting with these symptoms.N A, Ahmad, D C, Metzopenaire +2 more sourcesEfficacy and safety of CT‐868, a novel, fully biased, dual glucagon‐like peptide‐1/glucose‐dependent insulinotropic polypeptide receptor agonist, in type 2 diabetes: A double‐blind, randomized placebo controlled phase 2 trial
Diabetes, Obesity and Metabolism, EarlyView.Abstract Aims
To assess the glycaemic efficacy and safety of CT‐868, a cAMP signal‐biased, dual glucagon‐like peptide‐1/glucose‐dependent insulinotropic polypeptide receptor agonist, in participants with type 2 diabetes (T2D). Materials and Methods
This 26‐week (W), phase 2, randomized, double‐blind placebo‐controlled trial enrolled adults with T2D ...Manu V. Chakravarthy, Michael A. Elliott, Luis Acosta, Gabriele E. Sonnenberg, Damian Bialonczyk, Jingtao Wu, Federico A. Argüelles‐Tello, Raymundo Garcia‐Reza, José Gerardo González‐González, Stig K. Hansen, Juan P. Frias +10 morewiley +1 more sourceEfficacy and safety of glucagon‐like peptide 1 receptor agonists across all health outcomes in type 2 diabetes: An umbrella review and evidence map of randomised controlled trials
Diabetes, Obesity and Metabolism, EarlyView.Abstract Aim
Glucagon‐like peptide 1 receptor agonists (GLP‐1RAs) have been established as effective treatments for type 2 diabetes, offering benefits beyond glycaemic control; however, their associations across multiple health outcomes remain insufficiently assessed.Dongjin Yeo, Yeona Jo, Jinyoung Jeong, Yi Deun Jeong, Ho Geol Woo, Yejun Son, Sunyoung Kim, Sang Youl Rhee, Dong Keon Yon +8 morewiley +1 more sourceFunctional Dyspepsia and Gastroparesis in Tertiary Care are Interchangeable Syndromes With Common Clinical and Pathologic Features
, 2021 Pankaj J. Pasricha, Madhusudan Grover, Katherine P. Yates, Thomas L. Abell, Cheryl E. Bernard, Kenneth L. Koch, Richard W. McCallum, Irene Sarosiek, Braden Kuo, Jiande Chen, Robert J. Shulman, Linda Lee, James Tonascia, Laura Miriel, Frank A. Hamilton, Gianrico Farrugia, Henry P. Parkman, Pankaj J. Pasricha, Robert Bulat, Robert Burns, Guillermo Barahona Hernandez, Megan McKnight, Braden Kuo, April Mendez, Kyle Staller, Andrea H. Thurler, Christopher Vélez, Casey J. Silvernale, Henry P. Parkman, Zubair Malik, Alan H. Maurer, Amiya Palit, Richard W. McCallum, Irene Sarosiek, Natalia Vega, Denise Vasquez, Sean Connery, Karina Espino, Marvin I. Friedman, Thomas L. Abell, Abigail Stocker, Bridget Cannon, Lindsay McElmurray, Kelly Cooper, Catherine McBride, Kenneth L. Koch, Lynn Baxter, Anya Brown, Paula S. Stuart, Amirah Abdullah, William J. Snape, Nata DeVole, Karen Earle, Kjersti Kirkeby, Candice Lee, Mimi Lin, Doug Troyer, Anna Bakonyi, Robert J. Shulman, Bruno P. Chumpitazi, Liz Febo‐Rodriguez, John M. Hollier, Cynthia Bouette, Heather Charron, Samuel Nurko, Stephanie Wall, Madeline Kane, Kent C. Williams, Lina Yossef‐Salameh, Frederick W. Woodley, Gianrico Farrugia, Madhusudan Grover, Cheryl E. Bernard, José Serrano, Frank A. Hamilton, Sherry Hall, S. Jill James, Rebecca Torrance, James Tonascia, Margaret Adamo, Patricia Belt, J.A. Dodge, Michele Donithan, Milana Isaacson, Linda Lee, Jill Meinert, Laura Miriel, Emily P. Sharkey, Jacqueline Smith, Michael S. Smith, Jürgen Floege, Mark L. Van Natta, Annette Wagoner, Laura Wilson, Goro Yamada, Katherine P. Yates +95 moreopenalex +2 more sourcesSafety and effectiveness of tirzepatide during Ramadan fasting: Real‐world evidence from patients with type 2 diabetes in Bangladesh
Diabetes, Obesity and Metabolism, EarlyView.Abstract Aims
Ramadan fasting poses challenges for patients with type 2 diabetes mellitus (T2DM) due to increased risks of hypoglycemia and metabolic fluctuations. Tirzepatide, a dual GIP/GLP‐1 receptor agonist, has shown marked efficacy in glycemic control and weight reduction.Muhammad Hafizur Rahman, Shahjada Selim, Faria Afsana, Md. Azizul Hoque, M. Saifuddin, Md. Shah Alam, Mirza Sharifuzzaman, Mohmmad Abdul Hannan, Md. Nazmul Hasan, A. B. M. Kamrul‐Hasan, Marufa Mustari, Afsar Ahammed +11 morewiley +1 more sourceBrentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine for Patients Aged 18–59 Years With Untreated Advanced Stage Classical Hodgkin Lymphoma: The Largest Real‐Life Series From Southern Italy Cancer Centers
European Journal of Haematology, EarlyView.ABSTRACT
BV + AVD is increasingly used for frontline treatment of stage III/IV cHL. Young adults and adults (Ya&A) were the most common patients treated with BV + AVD in clinical trials but have not been studied in non‐trial settings. We conducted a real‐life study in secondary and tertiary cancer centers to evaluate the PFS in 18–59 years aged ...Marco Picardi, Annamaria Vincenzi, Claudia Giordano, Novella Pugliese, Alessia Scarpa, Assunta Lombardi, Elena Vigliar, Giancarlo Troncone, Rosaria Cappiello, Massimo Mascolo, Giovanni Esposito, Maria Prastaro, Ciro Santoro, Roberta Esposito, Carlo Gabriele Tocchetti, Ciro Mainolfi, Rosa Fonti, Silvana Del Vecchio, Fabio Trastulli, Mario Annunziata, Rossella Iula, Catello Califano, Marianna Carchia, Marcello Persico, Alessia Salemme, Emanuele Nicolai, Andrea Soricelli, Marco Salvatore, Fabrizio Pane +28 morewiley +1 more source